January 21, 2022
The difference between retina’s biological age and person’s real age linked to heightened death risk, with a team of Australian investigators finding that evidence suggests the microvasculature in the retina may be a reliable indicator of the overall health of the body’s circulatory system and the brain.
January 20, 2022
The improvement became evident during an average time of 6 months.
January 19, 2022
According to researchers, gaining a good understanding of what Musashi proteins do and how to manipulate their function could lead to the development of a universal therapy for blinding diseases.
January 18, 2022
ASCENT, REGENXBIO’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.
The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.
January 13, 2022
Real-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.
January 12, 2022
Investigators have cited the need for pharmacologic and non-pharmacologic interventions to improve the ongoing burden after hospitalization for COVID-19.
January 11, 2022
In light of another unprecedented year filled with technological advancements and pivots as a result of the pandemic, Joshua Mali, MD, offers his top 5 predictions in ophthalmology for 2022.
Recent literature review reveals dearth of data, highlights need for more research.
January 10, 2022
The difference in visual acuities based on CST fluctuations in these patients with diabetic macular edema remained significant.
